Accumulated Treatment Cost of New Therapies in Multiple Myeloma- Comparing the Combination of Daratumumab, Bortezomib and Dexamethasone with Carfilzomib and Dexamethasone For WHO Have Received at Least One Prior Therapy in Brazil

Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.2583
https://www.valueinhealthjournal.com/article/S1098-3015(17)32917-0/fulltext
Title : Accumulated Treatment Cost of New Therapies in Multiple Myeloma- Comparing the Combination of Daratumumab, Bortezomib and Dexamethasone with Carfilzomib and Dexamethasone For WHO Have Received at Least One Prior Therapy in Brazil
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32917-0&doi=10.1016/j.jval.2017.08.2583
First page : A876
Section Title : SELECTED HEALTH CARE TREATMENT STUDIES -MEDICAL DEVICE/DIAGNOSTICS
Open access? : No
Section Order : 2384
Categories :
Tags :
Regions :
ViH Article Tags :